These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 8672855

  • 1. [Expression of the MDR1 gene in five human cell lines of medullary thyroid cancer and reversion of the resistance to doxorubicine by ciclosporin A and verapamil].
    Massart C, Gibassier J, Lucas C, Pourquier P, Robert J.
    Bull Cancer; 1996 Jan; 83(1):39-45. PubMed ID: 8672855
    [Abstract] [Full Text] [Related]

  • 2. [Modulation of cisplatin cytotoxicity by amphotericin B in six human cell lines of medullary thyroid cancer].
    Massart C, Gibassier J, Le Gall F, Raoul ML, Leclech G, Lucas C.
    Bull Cancer; 1996 Aug; 83(8):619-25. PubMed ID: 8869041
    [Abstract] [Full Text] [Related]

  • 3. Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line.
    Massart C, Gibassier J, Raoul M, Pourquier P, Leclech G, Robert J, Lucas C.
    Anticancer Drugs; 1995 Feb; 6(1):135-46. PubMed ID: 7756676
    [Abstract] [Full Text] [Related]

  • 4. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
    Muller C, Goubin F, Ferrandis E, Cornil-Scharwtz I, Bailly JD, Bordier C, Bénard J, Sikic BI, Laurent G.
    Mol Pharmacol; 1995 Jan; 47(1):51-6. PubMed ID: 7838133
    [Abstract] [Full Text] [Related]

  • 5. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
    Zhu L, Lang J, Shen K.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L, Fouladdel S, Shafiee A, Amini M, Ghaffari SM, Azizi E.
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [Abstract] [Full Text] [Related]

  • 7. Intrinsic drug resistance in a human medullary thyroid carcinoma cell line: association with overexpression of mdrl gene and low proliferation fraction.
    Yang KP, Liang YF, Samaan NA.
    Anticancer Res; 1991 Apr; 11(3):1065-8. PubMed ID: 1888139
    [Abstract] [Full Text] [Related]

  • 8. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 9. Effect of PSC 833 on the efficacy of doxorubicin in vitro in a medullary thyroid carcinoma cell line.
    Massart C, Gibassier J, Denais A, Genetet N.
    Anticancer Res; 1998 May; 18(4C):2953-6. PubMed ID: 9713490
    [Abstract] [Full Text] [Related]

  • 10. Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line.
    Li J, Xu LZ, Yao JJ, Guo WJ, Xia P, Chen Y.
    Acta Pharmacol Sin; 2001 Nov; 22(11):1023-7. PubMed ID: 11749795
    [Abstract] [Full Text] [Related]

  • 11. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers.
    Abbaszadegan MR, Cress AE, Futscher BW, Bellamy WT, Dalton WS.
    Cancer Res; 1996 Dec 01; 56(23):5435-42. PubMed ID: 8968098
    [Abstract] [Full Text] [Related]

  • 12. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer.
    Campling BG, Young LC, Baer KA, Lam YM, Deeley RG, Cole SP, Gerlach JH.
    Clin Cancer Res; 1997 Jan 01; 3(1):115-22. PubMed ID: 9815546
    [Abstract] [Full Text] [Related]

  • 13. Molecular cytogenetic characterization of doxorubicin-resistant neuroblastoma cell lines: evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region.
    Flahaut M, Mühlethaler-Mottet A, Martinet D, Fattet S, Bourloud KB, Auderset K, Meier R, Schmutz NB, Delattre O, Joseph JM, Gross N.
    Genes Chromosomes Cancer; 2006 May 01; 45(5):495-508. PubMed ID: 16450357
    [Abstract] [Full Text] [Related]

  • 14. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L, Tong Y, Jin Y, Zhou S, Zhang Y, Yang X, Mao N.
    Chin Med J (Engl); 2001 Sep 01; 114(9):929-32. PubMed ID: 11780384
    [Abstract] [Full Text] [Related]

  • 15. Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism.
    Zatelli MC, Luchin A, Piccin D, Tagliati F, Bottoni A, Vignali C, Bondanelli M, degli Uberti EC.
    J Clin Endocrinol Metab; 2005 Oct 01; 90(10):5754-60. PubMed ID: 16091477
    [Abstract] [Full Text] [Related]

  • 16. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I, Sugiyama H, Kanazawa S, Hemmi H.
    Cancer Chemother Pharmacol; 2002 Jun 01; 49(6):438-44. PubMed ID: 12107547
    [Abstract] [Full Text] [Related]

  • 17. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J, Mucsi I, Nacsa J, Hevér A, Gyémánt N, Ugocsai K, Hegyes P, Kiessig S, Gaal D, Lage H, Varga A.
    Anticancer Res; 2004 Jun 01; 24(2B):865-71. PubMed ID: 15161039
    [Abstract] [Full Text] [Related]

  • 18. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C, Wellham LL.
    Anticancer Res; 2003 Jun 01; 23(3B):2681-90. PubMed ID: 12894558
    [Abstract] [Full Text] [Related]

  • 19. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC.
    Cancer Chemother Pharmacol; 2006 Nov 01; 58(5):640-53. PubMed ID: 16544145
    [Abstract] [Full Text] [Related]

  • 20. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.
    Kim JH, Chung JB, Park IS, Kim BS, Yoo NC, Choi JH, Roh JK, Kim HS, Kwon OH, Lee KS.
    Yonsei Med J; 1993 Mar 01; 34(1):35-44. PubMed ID: 8397460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.